Feb 02,2018

Health start-up Medopad raises $28 million after striking over $140 million in China deals

British health tech start-up Medopad has raised $28 million in its first round of financing, after having struck �100 million ($143 million) worth of deals in China with firms including Tencent. Medopad was one of a number of U.K. firms to join British Prime Minister Theresa May on her visit to China this week, as the U.K. leader discussed trade and security with Chinese President Xi Jinping. The Series A round was led by Hong-Kong listed NWS Holdings, the construction and transport flagship of Chinese corporation New World Development. UBS served as a financial advisor to Medopad, overseeing the deal.

FUNDING SERIES A
View Analyst & Ambassador Comments
Go to original news
Feb 06,2018

AI pathology company Paige.AI raises $25M in funding

Paige.AI, a health technology company that applies artificial intelligence to pathology for cancer diagnosis and treatment, recently announced it landed $25 million in Series A funding, led by Jim Breyer of Breyer Capital. The New York-based company plans to continue to develop computational programs across diagnostic pathology. It will start by focusing on clinical applications in breast cancer, prostate cancer, and other common cancers.

FUNDING SERIES A
View Analyst & Ambassador Comments
Go to original news
Mar 28,2018

LetsGetChecked Raises $12M to Bring Personal Health Tests Into the Homes of Millions

LetsGetChecked, the medical health testing platform that allows customers to access regulated laboratory testing and self-test from the comfort of home, today announces the closing of $12 million in Series A funding. Led by Optum Ventures, the independent venture fund of health services leader Optum, and Qiming Venture Partners, a leading Chinese venture capital firm, the funding will be used to scale the company, fuel development of the technology platform linking customers to laboratories, and grow the full clinical support team.

FUNDING SERIES A
View Analyst & Ambassador Comments
Go to original news
May 23,2018

OWKIN Scores Additional Financing

OWKIN, the AI startup that uses machine learning to augment medical and biology research, today announced it has closed an additional Series A investment round extension with GV, raising a total of $18 million to-date. The capital raised will be used to continue the development of its AI platform, strengthen the company's strategic partnerships, and support internal growth.

FUNDING SERIES A
View Analyst & Ambassador Comments
Go to original news
Jun 18,2018

Insilico Medicine has raised $6M

Insilico Medicine has raised $6 million USD through a private offering of securities for its artificial intelligence-based drug discovery and aging research, according to the SEC form registered by the company.

FUNDING SERIES A
View Analyst & Ambassador Comments
Go to original news
Feb 20,2019

AI-company Aidence raises €10 million Series A to revolutionise the medical imaging industry

Aidence, a company that is bringing the full potential of Artificial Intelligence into the hands of medical professionals in medical imaging and disease detection, has completed a €10 million Series A funding round. The round was led by INKEF Capital and co-investor Rabo Ventures, alongside existing investors Northzone, HenQ and Health Innovations. This investment brings Aidence's total funding to €12.5 million.

FUNDING SERIES A
View Analyst & Ambassador Comments
Go to original news
Mar 07,2019

Owkin Closes New Round Led by F-Prime

Owkin, a NYC-based company which builds machine learning technologies and infrastructure to enable medical research, received a funding round of undisclosed amount. The round was led by F-Prime Capital and Eight Roads Ventures, joined by GV, Cathay Innovation and NJF Capital. In conjunction with the funding, Alex Pasteur, Partner at F-Prime Capital, joined Owkin�s board. The company intends to use the funds to expand its partner network worldwide and deploy its flagship machine learning platform to augment medical research.

FUNDING SERIES A
View Analyst & Ambassador Comments
Go to original news
Jun 04,2020

DermaSensor Inc. Announces $11.5 Million in Series A Preferred Funding to Advance Skin Cancer Care

DermaSensor Inc., a health technology company designing tools to better equip primary care providers for skin cancer checks, today announced $11.5 million in Series A Preferred Stock financing, bringing the company�s total funding to date to $17 million. The lead investors in this $11.5 million financing were Dr. Maurice R. Ferre, David Matlin, Chris Dewey and SternAegis Ventures. Ceros Financial Services acted as exclusive placement agent for a significant portion of this Series A financing.

FUNDING SERIES A
View Analyst & Ambassador Comments
Go to original news
Jun 30,2020

French-American AI Startup Owkin Closes $18M Series A To Make Medical Research More Collaborative

This morning Owkin, a medical research company that uses machine learning, announced that its Series A funding round has reached $70 million. This comes after Mubadala Capital and Bpifrance entered with a late $18 million in investment. The Series A has been in the works for some time. The money has trickled in periodically. In May it announced a $25 million dollar raise. But the Series A round dates back at least two years. In 2018 the company reported that the Series A pot was up to $18.1 million.

FUNDING SERIES A
View Analyst & Ambassador Comments
Go to original news
Aug 14,2020

CancerIQ raises $4.8M for its early cancer detection platform

CancerIQ, a Chicago startup that helps health care providers identify patients who have a genetic predisposition to certain cancers, announced $4.8 million in new funding this week. The Series A round was led by HealthX Ventures, a VC firm led by Mark Bakken, the founder of Nordic Consulting. Other backers include Chicago-based Impact Engine and Lightbank.

FUNDING SERIES A
View Analyst & Ambassador Comments
Go to original news
Subscribe to SERIES A